Scholarly Index
Philip H. Li
University of Hong Kong; 7,143 total citations; 200 total publications; best world rank #30
University of Hong Kong
7,143Total citations
200Total publications
28H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Drug-Induced Adverse Reactions | Lifetime | 428 | CN 3 | 94.64 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 733 | CN 21 | 83.61 |
| Drug-Induced Adverse Reactions | 2021-2025 | 30 | CN 1 | 97.49 |
| Contact Dermatitis and Allergies | 2021-2025 | 61 | CN 1 | 95.92 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 97 | CN 1 | 94.77 |
| Urticaria and Related Conditions | 2021-2025 | 114 | CN 4 | 94.82 |
| Food Allergy and Anaphylaxis Research | 2021-2025 | 267 | CN 34 | 93.08 |
| Mast cells and histamine | 2021-2025 | 150 | CN 8 | 89.42 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 154 | CN 25 | 83.06 |
| Autoimmune Bullous Skin Diseases | 2021-2025 | 574 | CN 36 | 83.98 |
| Pharmaceutical studies and practices | 2021-2025 | 593 | CN 25 | 80.58 |
| Hemophilia Treatment and Research | 2021-2025 | 345 | CN 12 | 83.52 |
| Vitamin K Research Studies | 2021-2025 | 276 | CN 34 | 57.75 |